Meditope Biosciences Lands $1,624,080 New Financing Round

  • Feed Type
  • Date
    10/9/2015
  • Company Name
    Meditope Biosciences
  • Mailing Address
    301 North Lake Avenue Pasadena, CA 91101 USA
  • Company Description
    Discovered at City of Hope, Meditope’s technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific Lego-like system that is able to attach and detach drugs to antibodies without the need for chemical conjugation.
  • Website
    http://www.meditope.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,624,080
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy